Nanoparticle-Based Drug Delivery
59 researchers across 10 institutions
Researchers in Arkansas investigate the design and application of nanoparticles for targeted drug delivery. This work focuses on creating novel nanomaterials and characterizing their interactions with biological systems. Investigations include developing methods to encapsulate therapeutic agents within nanoparticles, controlling the release rate of drugs, and enhancing the specificity of drug targeting to diseased cells or tissues. Studies explore various nanoparticle types, such as liposomes, polymeric nanoparticles, and inorganic nanoparticles, and their potential for treating conditions ranging from cancer to infectious diseases.
This research holds significant relevance for Arkansas's public health and economic development. By improving the efficacy and reducing the side effects of drug therapies, this work can contribute to better patient outcomes and potentially lower healthcare costs across the state. The development of advanced drug delivery systems also aligns with the growth of the biotechnology and pharmaceutical sectors, fostering innovation and potential commercialization opportunities within Arkansas.
This area of study draws on expertise from materials science, pharmacology, toxicology, and immunology. Engagement spans multiple Arkansas institutions, including universities and federal research centers, fostering a collaborative environment for advancing drug delivery technologies.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Ruud P.M. Dings | UAMS | 40 | 5,225 | Grant PI High Impact | |
| Gang� Li | UAMS | 38 | 5,080 | High Impact | |
| Sunil Sharma | UAMS | 37 | 4,990 | High Impact | |
| Thallapuranam Krishnaswamy Suresh Kumar | University of Arkansas | 31 | 3,546 | Grant PI High Impact | |
| Z. Ryan Tian | University of Arkansas | 31 | 4,288 | Grant PI High Impact | |
| Muhammad Rizwan | UA Little Rock | 29 | 3,253 | High Impact | |
| Ahmed Alzamly | UA Little Rock | 26 | 1,837 | ||
| Noureen Siraj | UA Little Rock | 25 | 1,734 | High Impact | |
| Christopher A. Newton | University of Arkansas | 24 | 2,469 | High Impact Grants | |
| Alexander Cook | University of Arkansas | 23 | 1,933 | High Impact | |
| Rebekah M. Samsonraj | University of Arkansas | 22 | 2,347 | Grant PI High Impact | |
| Samir V. Jenkins | UAMS | 21 | 1,427 | High Impact | |
| J. Gandy | UAMS | 20 | 1,655 | High Impact | |
| Nawab Ali | UA Little Rock | 19 | 1,693 | Grant PI | |
| Young Hye Song | University of Arkansas | 18 | 1,386 | Grant PI | |
| Asya Ozkızılcık | University of Arkansas | 17 | 511 | ||
| Azemat Jamshidi‐Parsian | UAMS | 17 | 1,533 | Grant PI | |
| Jian Jin | UAMS | 16 | 871 | ||
| Wenbo Niu | University of Arkansas | 14 | 947 | ||
| Brandon S.B. Canup | NCTR | 13 | 1,356 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 1,968
- 2 Massachusetts General Hospital 1,404
- 3 The University of Texas MD Anderson Cancer Center 1,051
- 4 Stanford University 1,031
- 5 University of California San Diego 882
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Nanoparticle-Based Drug Delivery.